Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart C Gordon

Showing results (111-120 of 214) with videos related to

Pageof 22
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 22, 2014
Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter studyNezam H Afdhal, Bruce R Bacon, Keyur Patel, et al.
Alimentary Pharmacology & Therapeutics|February 18, 2022
Review article: switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current dataYoung-Suk Lim, Wai-Kay Seto, Masayuki Kurosaki, et al.
Antiviral Therapy|October 11, 2012
A Phase I, randomized, placebo-controlled, 3-day, ascending-dose study of GS-9451, an NS3/4A protease inhibitor, in genotype 1 hepatitis C patientsEric J Lawitz, John M Hill, Thomas Marbury, et al.
Journal of Clinical Gastroenterology|April 7, 2020
Low Uptake of Direct-acting Antiviral Therapy Among Hepatitis C Patients With Advanced Liver Disease and Access to Care, 2014-2017Philip R Spradling, Jian Xing, Loralee B Rupp, et al.
Journal of Clinical Gastroenterology|June 8, 2017
Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015Philip R Spradling, Jian Xing, Loralee B Rupp, et al.
Gastroenterology|April 27, 2017
Hepatitis C Virus Infection Care Pathway-A Report From the American Gastroenterological Association Institute HCV Care Pathway Work GroupFasiha Kanwal, Bruce R Bacon, Lauren A Beste, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2016
Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare SettingsPhilip R Spradling, Jian Xing, Loralee B Rupp, et al.
Hepatology Communications|May 14, 2025
Treatment of pruritus in primary sclerosing cholangitis: Analysis of the consortium for autoimmune liver disease registryRichard Dean, Maryam Yazdanfar, Joseph Zepeda, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2017
Primary Sclerosing Cholangitis Is Not Rare Among Blacks in a Multicenter North American ConsortiumDavid S Goldberg, Cynthia Levy, Kidist Yimam, et al.
Digestive Diseases and Sciences|August 12, 2016
Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort StudyMonique A Foster, Jian Xing, Anne C Moorman, et al.
Pageof 22

Showing results (111-120 of 214) with videos related to

Sort By:
Pageof 22
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 22, 2014
Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter studyNezam H Afdhal, Bruce R Bacon, Keyur Patel, et al.
Alimentary Pharmacology & Therapeutics|February 18, 2022
Review article: switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current dataYoung-Suk Lim, Wai-Kay Seto, Masayuki Kurosaki, et al.
Antiviral Therapy|October 11, 2012
A Phase I, randomized, placebo-controlled, 3-day, ascending-dose study of GS-9451, an NS3/4A protease inhibitor, in genotype 1 hepatitis C patientsEric J Lawitz, John M Hill, Thomas Marbury, et al.
Journal of Clinical Gastroenterology|April 7, 2020
Low Uptake of Direct-acting Antiviral Therapy Among Hepatitis C Patients With Advanced Liver Disease and Access to Care, 2014-2017Philip R Spradling, Jian Xing, Loralee B Rupp, et al.
Journal of Clinical Gastroenterology|June 8, 2017
Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015Philip R Spradling, Jian Xing, Loralee B Rupp, et al.
Gastroenterology|April 27, 2017
Hepatitis C Virus Infection Care Pathway-A Report From the American Gastroenterological Association Institute HCV Care Pathway Work GroupFasiha Kanwal, Bruce R Bacon, Lauren A Beste, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2016
Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare SettingsPhilip R Spradling, Jian Xing, Loralee B Rupp, et al.
Hepatology Communications|May 14, 2025
Treatment of pruritus in primary sclerosing cholangitis: Analysis of the consortium for autoimmune liver disease registryRichard Dean, Maryam Yazdanfar, Joseph Zepeda, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2017
Primary Sclerosing Cholangitis Is Not Rare Among Blacks in a Multicenter North American ConsortiumDavid S Goldberg, Cynthia Levy, Kidist Yimam, et al.
Digestive Diseases and Sciences|August 12, 2016
Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort StudyMonique A Foster, Jian Xing, Anne C Moorman, et al.
Pageof 22